Oramed Pharmaceuticals's three largest insider shareholders as of June 09, 2026 are Nadav Kidron (President And Ceo, 3.42Mn shares), Joshua Hexter (Coo Cbo, 1.16Mn shares), Miriam Kidron (Chief Scientific Officer, 1.13Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Kevin Rakin | - | 46,661 | 0 | 22 Mar, 2022 |
| Nadav Kidron | President And Ceo | 3,422,243 | 0 | 31 Mar, 2026 |
| Miriam Kidron | Chief Scientific Officer | 1,133,138 | 0 | 31 Mar, 2026 |
| Leonard Sank | - | 134,531 | 0 | 09 Jun, 2025 |
| Joshua Hexter | Coo Cbo | 1,160,384 | 0 | 18 Mar, 2026 |
| Michael Rabinowitz | Chief Commercial Officer | 109,468 | 0 | 05 Jan, 2022 |
| Avraham Gabay | Chief Financial Officer | 745,145 | 0 | 18 Mar, 2026 |
| Arie Mayer | - | 168,009 | 0 | 05 Jan, 2026 |
| David Silberman | Chief Financial Officer | 366,500 | 0 | 08 Jan, 2024 |
| Michael Rabinowitz | Chief Commercial Officer | 126,143 | 0 | 04 Jan, 2023 |
| Netanel Derovan | Chief Legal Officer | 149,500 | 0 | 31 May, 2023 |
| Yadin Rozov | - | 155,320 | 0 | 08 Jan, 2024 |
| Benjamin Shapiro | - | 123,220 | 0 | 05 Jan, 2026 |
| Daniel Aghion | - | 113,441 | 0 | 02 Jan, 2026 |
| Yehuda Reznick | - | 105,180 | 0 | 05 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Mar, 2026 | Nadav Kidron | Common Stock | D | 44,818 | $3.31 | 3,422,243 | D | F |
| 30 Mar, 2026 | Miriam Kidron | Common Stock | D | 435,084 | $3.31 | 1,133,138 | D | F |
| 17 Mar, 2026 | Joshua Hexter | Common Stock | A | 95,889 | $0.00 | 1,160,384 | D | A |
| 17 Mar, 2026 | Miriam Kidron | Common Stock | A | 119,558 | $0.00 | 1,568,222 | D | A |
| 17 Mar, 2026 | Nadav Kidron | Common Stock | A | 167,005 | $0.00 | 3,422,243 | D | A |
| 17 Mar, 2026 | Avraham Gabay | Common Stock | A | 95,889 | $0.00 | 745,145 | D | A |
| 12 Mar, 2026 | Nadav Kidron | Common Stock | D | 100,000 | $0.00 | 3,255,238 | D | G |
| 22 Jan, 2026 | Nadav Kidron | Common Stock | A | 109,000 | $0.00 | 3,355,238 | D | M |
| 22 Jan, 2026 | Miriam Kidron | Common Stock | A | 19,000 | $0.00 | 1,448,664 | D | M |
| 22 Jan, 2026 | Avraham Gabay | Common Stock | A | 19,000 | $0.00 | 649,256 | D | M |
| 22 Jan, 2026 | Joshua Hexter | Common Stock | A | 19,000 | $0.00 | 1,064,495 | D | M |
| 22 Jan, 2026 | Nadav Kidron | Performance Stock Units | D | 109,000 | $0.00 | 0 | D | M |
| 22 Jan, 2026 | Avraham Gabay | Performance Stock Units | D | 19,000 | $0.00 | 0 | D | M |
| 22 Jan, 2026 | Miriam Kidron | Performance Stock Units | D | 19,000 | $0.00 | 0 | D | M |
| 22 Jan, 2026 | Joshua Hexter | Performance Stock Units | D | 19,000 | $0.00 | 0 | D | M |
| 14 Jan, 2026 | Miriam Kidron | Common Stock | D | 86,166 | $0.00 | 1,343,498 | D | G |
| 31 Dec, 2025 | Yehuda Reznick | Common Stock | A | 30,000 | - | 98,930 | D | A |
| 31 Dec, 2025 | Joshua Hexter | Common Stock | A | 97,328 | $0.00 | 930,495 | D | A |
| 31 Dec, 2025 | Nadav Kidron | Common Stock | A | 232,640 | $0.00 | 2,919,238 | D | A |
| 31 Dec, 2025 | Yehuda Reznick | Common Stock | A | 30,000 | - | 98,930 | D | A |